Sign in
GTCO58.40+1.24%ZENITHBANK46.10-0.43%UBA32.85+0.92%ACCESSCORP22.30-1.10%FBNH28.70+0.35%STANBIC56.25+1.62%FCMB8.95-0.55%WEMABANK11.50+2.21%DANGCEM462.00+0.65%BUACEMENT95.40-0.22%WAPCO38.25+1.86%NESTLE1180.00-0.42%DANGSUGAR36.20+0.83%FLOURMILL64.55+1.49%UNILEVER18.45-1.07%NB35.60+2.45%GUINNESS64.10+0.16%SEPLAT5800.00+1.92%GTCO58.40+1.24%ZENITHBANK46.10-0.43%UBA32.85+0.92%ACCESSCORP22.30-1.10%FBNH28.70+0.35%STANBIC56.25+1.62%FCMB8.95-0.55%WEMABANK11.50+2.21%DANGCEM462.00+0.65%BUACEMENT95.40-0.22%WAPCO38.25+1.86%NESTLE1180.00-0.42%DANGSUGAR36.20+0.83%FLOURMILL64.55+1.49%UNILEVER18.45-1.07%NB35.60+2.45%GUINNESS64.10+0.16%SEPLAT5800.00+1.92%
Company Intelligence Terminal · Healthcare · Pharmaceuticals

FIDSON · Fidson Healthcare Plc

Fidson Healthcare Plc

FIDSON
NGXEquity · Ordinary SharesHealthcarePharmaceuticals
17.85NGN+1.42%
Market cap ₦41.00B · as of 17 Jun 2026, 10:33
Ask about FIDSON
Current price
17.85NGN
Open
17.60
Previous close
17.60
Today's range
17.55 – 18.05
52-week high
18.56
52-week low
17.12
Deals
813
Volume
7.1M
Value traded
₦126.7M
Market cap
₦41.00B
YTD performance
+1.42%

Company profile

Fidson Healthcare Plc is a leading healthcare operator in Nigeria, with operations spanning multiple states and a track record across investment cycles.

CEO
Fidelis Ayebae
HQ
Lagos
Founded
1995
Employees
900
Sector
Healthcare
Sub-sector
Pharmaceuticals
Ticker
FIDSON
Website
fidson.ng
Beta
0.97
AI-generated summary

Fidson Healthcare Plc (FIDSON) operates in Nigeria's healthcare value chain with an estimated FY2024 revenue of ₦33bn and PAT of ₦4bn. Headline ROE is 10.5% and leverage sits at 0.50x debt-to-equity, mapping to a composite risk score of 26/100 (Low).

Bull case
  • Scale leadership within its healthcare sub-sector with durable distribution moat.
  • Resilient ROE supports re-rating if rates ease in H2.
  • Capital-light reinvestment runway versus listed peers.
Bear case
  • FX volatility could compress imported-input margins.
  • Working-capital build-up in a 27.5% MPR environment.
  • Sector regulatory cadence could front-load compliance cost.

Key risks

  • Macro: persistent inflation > 25% pressuring real demand.
  • Sector-specific regulatory action and tariff resets.
  • Single-market concentration in Nigeria.

Recent developments

  • Board recommended final dividend at last AGM cycle.
  • Operational expansion announced in Lagos corridor.
  • Engagement with CBN on FX repatriation framework noted in latest filing.

Recent news

  • positiveProshare Markets· 09 Jun
    Fidson Healthcare Plc signs MoU with CBN on FX repatriation framework
  • neutralNGX Wire· 07 Jun
    FIDSON crosses key technical level on rising volume
  • negativeProshare Research· 04 Jun
    Analysts trim FIDSON FY26 EPS estimate by 4% on margin pressure
  • positiveBusinessDay· 01 Jun
    Fidson Healthcare Plc expands Lagos operations with NGN 0.8bn capex